EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn’s Disease-associated Perianal Fistulas from Cryptoglandular Fistulas

Laura F Ouboter iD, Ciska Lindelauf, Qinyue Jiang, Mette Schreurs, Tamim R Abdelaal, Sietse J Luk, Marieke C Barnhoorn, Willem E Hueting, Ingrid J Han-Geurts, Koen C M J Peeters, Fabian A Holman, Frits Koning und 2 weitere

Inflammatory Bowel Diseases · 04.11.2024 · 30 (11) · 2146-2161

DOI: 10.1093/ibd/izae103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 22.05.2024. Verfasst von Laura F Ouboter und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Crohn Disease, Rectal Fistula, Th1 Cells, Th17 Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Perianal fistulas are a debilitating complication of Crohn’s disease (CD). Due to unknown reasons, CD-associated fistulas are in general more difficult to treat than cryptoglandular fistulas (non-CD-associated). Understanding the immune cell landscape is a first step towards the development of more effective therapies for CD-associated fistulas. In this work, we characterized the composition and spatial localization of disease-associated immune cells in both types of perianal fistulas by high-dimensional analyses.

Methods

We applied single-cell mass cytometry (scMC), spectral flow cytometry (SFC), and imaging mass cytometry (IMC) to profile the immune compartment in CD-associated perianal fistulas and cryptoglandular fistulas. An exploratory cohort (CD fistula, n = 10; non-CD fistula, n = 5) was analyzed by scMC to unravel disease-associated immune cell types. SFC was performed on a second fistula cohort (CD, n = 10; non-CD, n = 11) to comprehensively phenotype disease-associated T helper (Th) cells. IMC was used on a third cohort (CD, n = 5) to investigate the spatial distribution/interaction of relevant immune cell subsets.

Results

Our analyses revealed that activated HLA-DR+CD38+ effector CD4+ T cells with a Th1/17 phenotype were significantly enriched in CD-associated compared with cryptoglandular fistulas. These cells, displaying features of proliferation, regulation, and differentiation, were also present in blood, and colocalized with other CD4+ T cells, CCR6+ B cells, and macrophages in the fistula tracts.

Conclusions

Overall, proliferating activated HLA-DR+CD38+ effector Th1/17 cells distinguish CD-associated from cryptoglandular perianal fistulas and are a promising biomarker in blood to discriminate between these 2 fistula types. Targeting HLA-DR and CD38-expressing CD4+ T cells may offer a potential new therapeutic strategy for CD-related fistulas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseRectal FistulaTh1 CellsTh17 CellsHLA-DR AntigensHumansMaleFemaleAdultADP-ribosyl Cyclase 1Flow CytometryMiddle Aged

Stichwörter der Autor:innen

Crohn’s diseasehigh-dimensional analysesperianal fistulas

Substanzen

HLA-DR AntigensADP-ribosyl Cyclase 1

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Immunology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
  • Bioinformatics Lab, Delft University of Technology, Delft, the Netherlands.
  • Systems and Biomedical Engineering Department, Faculty of Engineering Cairo University, Giza, Egypt.
  • Department of Hematology, Leiden University Medical Center, Leiden, the Netherlands.

ORCID-Profile: Laura F Ouboter

Zitieren

APA

Ouboter, L. F., Lindelauf, C., Jiang, Q., Schreurs, M., Abdelaal, T. R., Luk, S. J., Barnhoorn, M. C., Hueting, W. E., Han-Geurts, I. J., Peeters, K. C. M. J., Holman, F. A., Koning, F., van der Meulen-de Jong, A. E., & Pascutti, M. F. (2024). Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn’s Disease-associated Perianal Fistulas from Cryptoglandular Fistulas. Inflammatory Bowel Diseases, 30(11), 2146-2161. https://doi.org/10.1093/ibd/izae103

Vancouver

Ouboter LF, Lindelauf C, Jiang Q, Schreurs M, Abdelaal TR, Luk SJ, et al. Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn’s Disease-associated Perianal Fistulas from Cryptoglandular Fistulas. Inflammatory Bowel Diseases. 2024;30(11):2146-2161. doi:10.1093/ibd/izae103

BibTeX
@article{Ouboter2024,
  author = {Ouboter, Laura F and Lindelauf, Ciska and Jiang, Qinyue and Schreurs, Mette and Abdelaal, Tamim R and Luk, Sietse J and Barnhoorn, Marieke C and Hueting, Willem E and Han-Geurts, Ingrid J and Peeters, Koen C M J and Holman, Fabian A and Koning, Frits and van der Meulen-de Jong, Andrea E and Pascutti, Maria Fernanda},
  title = {Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn’s Disease-associated Perianal Fistulas from Cryptoglandular Fistulas},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  volume = {30},
  number = {11},
  pages = {2146--2161},
  doi = {10.1093/ibd/izae103}
}
Kostenlos starten →